Literature DB >> 28993106

The antitubercular activity of various nitro(triazole/imidazole)-based compounds.

Maria V Papadopoulou1, William D Bloomer2, Howard S Rosenzweig3.   

Abstract

Twenty three 3-nitrotriazole- and five nitroimidazole-based compounds, mostly amides, were screened for antitubercular activity against Mycobacterium tuberculosis H37Rv (Mtb H37Rv) under aerobic or low oxygen conditions, intracellular activity in murine J774 macrophages or THP-1 cells, activity against resistant Mtb strains as well as cytotoxicity in normal cells. Compounds with a Minimum Inhibitory Concentration (MIC) less than 10μM and 10-50μM were characterized as active and moderately active, respectively, whereas compounds with a MIC >50μM were characterized inactive. Fifteen 3-nitrotriazole-based compounds were active or moderately active against aerobic Mtb and thirteen of them were bactericidal, however, only four 3-nitrotriazoles were moderately active against anaerobic Mtb. All examined 2-nitroimidazole-based compounds were inactive against aerobic Mtb, and from the ones examined against anaerobic Mtb, only one was found moderately active. All examined compounds demonstrated intracellular activity and lack of cross-resistance. The five active 3-nitrotriazoles demonstrated good selectivity for Mtb. In conclusion, these classes of 3-nitrotriazole-based compounds merit further investigation as potential antitubercular agents.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antitubercular agents; Mycobacterium tuberculosis; Nitroimidazoles; Nitrotriazoles

Mesh:

Substances:

Year:  2017        PMID: 28993106     DOI: 10.1016/j.bmc.2017.09.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Pharmacologic potential of new nitro-compounds as antimicrobial agents against nosocomial pathogens: design, synthesis, and in vitro effectiveness.

Authors:  Jéssica Tauany Andrade; Silmara Lucia Grego Alves; William Gustavo Lima; Carla Daiane Ferreira Sousa; Lucas Fernandes Carmo; Nívea Pereira De Sá; Fernanda Barbara Morais; Susana Johann; José Augusto Ferreira Perez Villar; Jaqueline Maria Siqueira Ferreira
Journal:  Folia Microbiol (Praha)       Date:  2019-08-10       Impact factor: 2.099

Review 2.  The Diverse Biological Activity of Recently Synthesized Nitro Compounds.

Authors:  Saúl Noriega; Jaime Cardoso-Ortiz; Argelia López-Luna; Ma Del Refugio Cuevas-Flores; Juan Armando Flores De La Torre
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-05

3.  New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design.

Authors:  Oxana Kazakova; Roxana Racoviceanu; Anastasiya Petrova; Marius Mioc; Adrian Militaru; Lucreția Udrescu; Mihai Udrescu; Adrian Voicu; Jason Cummings; Gregory Robertson; Diane J Ordway; Richard A Slayden; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

Review 4.  An insight on medicinal attributes of 1,2,4-triazoles.

Authors:  Ranjana Aggarwal; Garima Sumran
Journal:  Eur J Med Chem       Date:  2020-07-27       Impact factor: 6.514

5.  Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.

Authors:  Titilayo O Johnson; Abayomi Emmanuel Adegboyega; Opeyemi Iwaloye; Omokehinde Abiodun Eseola; Winfried Plass; Boluwatife Afolabi; Damilare Rotimi; Eman I Ahmed; Ashraf Albrakati; Gaber E Batiha; Oluyomi Stephen Adeyemi
Journal:  J Pharmacol Sci       Date:  2021-05-23       Impact factor: 3.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.